Beshir, Khalid B.
Parr, Jonathan B.
Cunningham, Jane
Cheng, Qin
Rogier, Eric
Funding for this research was provided by:
Wellcome Trust
National Institutes of Health (R01AI132547)
Bill and Melinda Gates Foundation (OPP1209843)
Article History
Received: 11 April 2022
Accepted: 17 June 2022
First Online: 24 June 2022
Change Date: 11 September 2022
Change Type: Update
Change Details: This article has been corrected since original publication; please see the linked erratum for futher details.
Change Date: 14 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12936-022-04281-9
Declarations
: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention, the Public Health Service, or the U.S. Department of Health and Human Services.
: Not applicable.
: Not applicable.
: JBP reports having received research support from the WHO and NIH relevant to the scope of this work. JBP also reports research support from Gilead Sciences, non-financial support from Abbott Laboratories, and an honorarium from Virology Education for studies of viral hepatitis and COVID-19, outside the scope of the current work.